Please login to the form below

Not currently logged in


This page shows the latest naloxone news and features for those working in and with pharma, biotech and healthcare.

Q&A: Kate Paxton

Q&A: Kate Paxton

I was very honoured to develop and launch the esteemed patient advocacy group Families Fighting Flu, and helping to launch the first community-ready nasal naloxone in the US during the

Latest news

More from news
Approximately 1 fully matching, plus 17 partially matching documents found.

Latest Intelligence

  • Deal Watch table for May 2014 Deal Watch table for May 2014

    N/D. AntiOp / Reckitt Benckiser. Supply and marketing agreement. Intranasal naloxone for opioid abuse in late clinical development.

  • Pharma deals during May 2014 Pharma deals during May 2014

    of alcohol abuse; and a supply and marketing agreement with AntiOp for intranasal naloxone for opioid abuse.

  • Pharma deals during November 2013 Pharma deals during November 2013

    The licence is for tamper resistant oxycodone (marketed in the US since 2010) and an oxycodone/naloxone combination marketed in Europe since 2009.

More from intelligence
Approximately 0 fully matching, plus 3 partially matching documents found.

Latest from PMHub

  • IOTOD: Improving Opioid Dependence Outcomes

    dependence. In addition to the standalone conference, IOTOD now includes online education, such as webcasts, reports, and resources and tools such as the take-home naloxone (THN) toolkit.

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs


Add my company
Hanson Zandi

Hanson Zandi is a Creative and Digital Healthcare Agency. We combine 30 years’ experience with the enthusiasm of a start-up...

Latest intelligence

Working together against COVID-19
Analysing social media conversations to see what HCPs are saying online about the global pandemic...
Vicky Bramham, Managing Director at OPEN Health PR shares tips on media relations during COVID-19
Vicky speaks with freelance health journalist Jacqui Thornton who gives her expert view on how best to approach media relations during this unprecedented time....
Are biobetters a market access opportunity?
Biobetters are biologics that have been improved compared to the marketed originator, for example in efficacy, safety, tolerability or dosing regimen....